Literature DB >> 1796399

PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA.

T Urano1, K Sumiyoshi, M H Pietraszek, Y Takada, A Takada.   

Abstract

The antigen levels of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) were assayed in the plasma and in the euglobulin fraction, and their contributions to the euglobulin clot lysis time (ECLT) and t-PA activity were analyzed. Total and free PAI-1 levels in both fractions showed significant positive correlation with ECLT (p less than 0.001), whereas t-PA antigen level did not have a high correlation coefficient with ECLT. t-PA activity showed significant negative correlation with ECLT (p less than 0.001) and positive correlation with free t-PA level (p less than 0.001), which was calculated by the ratio of the concentrations of t-PA-PAI-1 complex and the free PAI-1. Thus free t-PA seems to dissolve the euglobulin clot and its concentration seems to be controlled by the concentration of free PAI-1. These findings were confirmed by the analyses of the effects of C1-inactivator and antibody against t-PA to regular ECLT and kaolin activated ECLT, the latter of which was only inhibited by the addition of C1-inactivator whereas the former was inhibited by anti-t-PA antibody.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1796399

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Plasma fibrinogen, tissue plasminogen activator, plasminogen activator inhibitor 1, and their related factors in three Japanese population samples.

Authors:  K A Koike; H Iso; T Shimamoto; M Kudo; U Umemura; S Sato; Y Naito; M Iida; Y Komachi
Journal:  Environ Health Prev Med       Date:  1998-10       Impact factor: 3.674

2.  The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treated with streptokinase.

Authors:  Johan B Nilsson; Kurt Boman; Jan-Håkan Jansson; Torbjörn Nilsson; Ulf Näslund
Journal:  J Thromb Thrombolysis       Date:  2007-08-25       Impact factor: 2.300

3.  High PAI activity with correlation to triglyceride and HDL cholesterol values in patients with coronary artery disease with no difference in survivors of myocardial infarction.

Authors:  K Ihnken; W Speiser; W Ruf; W Thiel; M Schlepper; G Müller-Berghaus
Journal:  Ann Hematol       Date:  1993-11       Impact factor: 3.673

4.  Postoperative changes in plasma tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.

Authors:  K Aoki; N Nishino; S Baba; T Urano; A Takada
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

5.  Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield.

Authors:  Lars L F G Valke; Danielle Meijer; Laurens Nieuwenhuizen; Britta A P Laros-van Gorkom; Nicole M A Blijlevens; Waander L van Heerde; Saskia E M Schols
Journal:  Res Pract Thromb Haemost       Date:  2022-03-15

6.  Accelerated fibrinolysis and its propagation on vascular endothelial cells by secreted and retained tPA.

Authors:  Tetsumei Urano; Yuko Suzuki
Journal:  J Biomed Biotechnol       Date:  2012-10-14

7.  The effect of dilution, pH and ionic strength of plasma on t-PA precipitation in euglobulin fraction.

Authors:  S Y Hong; H K Shin; D H Yang
Journal:  Korean J Intern Med       Date:  1992-07       Impact factor: 2.884

Review 8.  Regulation of plasminogen activation on cell surfaces and fibrin.

Authors:  T Urano; F J Castellino; Y Suzuki
Journal:  J Thromb Haemost       Date:  2018-05-20       Impact factor: 5.824

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.